Atlas Trials

Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA)

Clinical trial NCT03420014 · UNKNOWN

Trial details

NCT number
NCT03420014
Sponsor
Philogen S.p.A.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Leiomyosarcoma
Start date
2018-12-27
Primary completion
2024-12-01
Enrollment
114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.